Universities are increasingly perceived as agents involved in regional development. It is now recognized that academic contributions to the socioeconomic environment go well beyond scientific investigation and teaching activities, and incorporate market-oriented initiatives to the academic mission. However, these effects are geographically bounded. Given these conditions, this article aims at addressing universities’ impacts upon output vectors of localized innovation ecosystems. Using data from cities and microregions in the state of Sao Paulo, Brazil observed throughout the period of 2002–2014, we address universities’ effects upon the local-level generation of patents and utility models, software production and emergence of knowledge-intensive entrepreneurship. Besides the scant available evidence on innovation ecosystems located outside developed economies, dealing with a developing country also means we are addressing an analytical unit in which universities play a critical role in terms of knowledge production and diffusion, a function of the weak competences of local firms. Findings support the hypothesis that major academic institutions lie at the heart of innovation ecosystems, but impacts are mostly local, happening more strongly at the level of cities. While the formation of human capital also contributes to innovative output, its impacts are of minor relevance as compared to higher education institutions that achieve excellence in research. This poses severe challenges for policymakers when targeting the formation and enhancement of initiatives to develop innovative ecosystems, particularly for peripheral areas. First, these regions are not likely to reap substantial benefits from proximity to successful hubs. Beyond that, creating local conditions is not as straightforward as sometimes announced in political discourse. In this regard, some fundamental vectors are not easily manipulated in the short-term and there seems to be fundamental importance attributed to long-term, evolutionary conditions. Such is the case for high-quality universities.
1 August 2019 in RAE: Revista de Administracao de Empresas
The dominant discourse on Entrepreneurial Ecosystems (EE) remains focused on the profile of a handful of successful locations. This has hindered a deeper comprehension of the economic mechanisms that shape evolutionary trends in entrepreneurial activity and how they operate in distinct places. We propose that EE have regularities, but they can also assume different configurations, i.e., varying combinations of influential dimensions. Through fuzzy set qualitative comparative analysis, we address this issue with data from the State of São Paulo, Brazil. This research focuses on five EE dimensions: Science & Technology, Human Capital, Market Dynamics, Business Dynamics, and Infrastructure. Findings point at the heterogeneous nature of EE distributed in three different paths. While configurations’ vary in terms of causal conditions, research universities, knowledge-intensive jobs and wider credit operations are core-causal conditions. Proximity to the main economic hub appears as a key differentiator among ecosystems.
Acredita-se que o investimento estrangeiro direto (IED) represente uma questão estratégica no âmbito dos sistemas de inovação dos países em desenvolvimento. Isso decorre de expectativas de que esse tipo específico de investimento possa causar choques positivos sobre as capacidades dos mercados receptores. O argumento do presente artigo, em consonância com a literatura dedicada, é que tais contribuições não ocorrem sem “atritos”, havendo uma complementaridade significativa entre os efeitos do IED e do quadro da política de inovação (em particular as iniciativas que influenciam o nível existente de capacidades absortivas sistêmicas). A partir de técnicas de dados em painel para países em desenvolvimento, estimamos funções de produção orientadas para avaliar a evolução dos sistemas nacionais de inovação. Os resultados sugerem que os impactos positivos de IED estão subordinados às capacidades absortivas dos sistemas de inovação de países em desenvolvimento. No entanto, suas contribuições são restritas, estando robustamente relacionadas apenas a ganhos de produtividade do trabalho.
In this paper, we intend to verify if more inclusive spin-offs tend to obtain better performance or access to funding sources. Thus, we have analyzed the spin-off companies of the State University of Campinas (Unicamp) in Brazil. The Inova Agency, i.e., the technology transfer office of Unicamp, provided the data concerning all university spin-offs. The outcomes indicate an unbalanced sample in terms of gender, and the same is expected regarding race and socioeconomic profile. We hope this study may serve as a basis for policymakers to better direct efforts to create and base policies that strengthen inclusion in scientific activities, especially those related to university-related entrepreneurial activities.
The pharmaceutical industry has undergone several changes and challenges, nowadays the industry is facing a R&D productivity crises. A series of questions arise from this fact, two of it can be highlighted as important for this study that are: how the industry is dealing with this crises? Does it bring new features to the sector? The answer that this article proposes it is also our argument, that is: the solution sought by the industry is both technological and organizational and it resides outside the large pharmaceutical enterprise's borders, therefore, those companies are using strategies, especially acquisitions of small biotech enterprises to incorporate new technologies that, arguably, will increase the large enterprise's innovative output. Therefore this article objective is to prove the argument. In order to achieve the objective proposed this work proposes to combine bibliographic research on the economic literature and the specialized literature on drug discovery techniques to describe this activity evolution, in addition, some important data will be present to sustain the assertions made. As a conclusion the article shows that the R&D activities evolution has created a biotechnology trajectory, in the pharmaceutical companies, that made the incorporation of small biotech enterprises a recurrent strategy.